(1R,1'S,3'R/1R,1'R,3'S)-L-054,264

(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 価格 もっと(2)

メーカー	製品番号	製品説明	CAS番号	包装	価格	更新時間	購入
富士フイルム和光純薬株式会社(wako)	W01TOC2444	(1R,1S,3R/1R,1R,3'S)-L-054,264	208706-12-1	1mg	￥47000	2024-03-01	購入
富士フイルム和光純薬株式会社(wako)	W01TOC2444	(1R,1S,3R/1R,1R,3'S)-L-054,264	208706-12-1	10mg	￥101000	2024-03-01	購入

(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 化学特性,用途語,生産方法

生物活性

Potent and selective somatostatin sst 2 receptor agonist (K i values are 4, 537, 2480, 3614 and 5017 nM for cloned human sst 2 , sst 1 , sst 4 , sst 3 and sst 5 receptors respectively).

(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 上流と下流の製品情報

原材料

準備製品

(1R,1'S,3'R/1R,1'R,3'S)-L-054,264 生産企業

名前	電話番号	電子メール	国籍	製品カタログ	優位度
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	19892	58
Hangzhou MolCore BioPharmatech Co.,Ltd.	+86-057181025280; +8617767106207	sales@molcore.com	China	49739	58
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	52927	58
3B Pharmachem (Wuhan) International Co.,Ltd.	821-50328103-801 18930552037	3bsc@sina.com	China	15848	69
Shanghai T&W Pharmaceutical Co., Ltd.	+86 21 61551611		China	9900	58
EMMX Biotechnology LLC	888-539-0666	info@emmx.com	United States	8449	60
BOC Sciences	--	info@bocsci.com	USA	0	65
Shanghai Universal Biotech Co.,Ltd	18768175414	gaojun@univ-bio.com	China	24998	58
TargetMol Chemicals Inc.	4008200310	marketing@tsbiochem.com	China	23963	58
Henan Alpha Chemical Co., Ltd.	0371-55013243 15324716602	2853979810@qq.com	China	10010	58

208706-12-1()キーワード:

---

• 208706-12-1
• N-[(1R)-2-[[[(1S*,3R*)-3-(AMINOMETHYL)CYCLOHEXYL]METHYL]AMINO]-1-(1H-INDOL-3-YLMETHYL)-2-OXOETHYL]SPIRO[1H-INDENE-1,4'-PIPERIDINE]-1'-CARBOXAMIDE
• S)-L-054,264
• (1R,1'S,3'R/1R,1'R,3'S)-L-054,264
• -methylethyl)-7a-methyl-inden-4-one
• S)-DuanPhos
• -Hydroxy pravastatin sodium salt
• (1R,1&rsquo
• -iodo-1&rsquo
• S)-Octahydro-1-(2&rsquo
• -methylethyl)-7a-methyl-inden-4-ol
• -(((2-Aminopropane-1,3-diyl)bis(oxy))bis(methylene))bis(phenylcyclopropanecarboxamide)
• Spiro[1H-indene-1,4'-piperidine]-1'-carboxamide, N-[(1R)-2-[[[3-(aminomethyl)cyclohexyl]methyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxoethyl]-
• N-?[(1R)?-?2-?[[[3-?(Aminomethyl)?cyclohexyl]?methyl]?amino]?-?1-?(1H-?indol-?3-?ylmethyl)?-?2-?oxoethyl]?-spiro[1H-?indene-?1,?4'-?piperidine]?-?1'-?carboxamide
• (1R,1S,3R/1R,1R,3'S)
• 264
• 3'R/1R
• 3'S)-L-054
• (1R,1'S,3'R/1R,1'R,3'S)L054,264,(1R,1'S,3'R/1R,1'R,3'S) L 054,264
• N-((2R)-1-(((3-(Aminomethyl)cyclohexyl)methyl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)spiro[indene-1,4'-piperidine]-1'-carboxamide
• (1R,1'S,3'R/1R,1'R,3'S)-L-054,264
• N-((2R)-1-(((3-(Aminomethyl)cyclohexyl)methyl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)spiro[indene-1,4'-piperidine]-1'-carboxamide